KMT2A-rearranged leukemia: from mechanism to drug development. Ernst P, Kyei P, Yokoyama A. Exp Hematol 2025 Sep 6:105247. doi: 10.1016/j.exphem.2025.105247.

Read + Share

Amedeo Smart

Independent Medical Education

Ernst P, Kyei P, Yokoyama A. KMT2A-rearranged leukemia: from mechanism to drug development. Exp Hematol 2025 Sep 6:105247. doi: 10.1016/j.exphem.2025.105247.
PMID: 40921261